Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice

Channels

Volumn 4, Issue 1, 2010, Pages 1-4

  Callaghan, Brid ^a,b   Adams, David J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Analgesia; Conotoxin; Dorsal root ganglion; N type calcium channel; Nicotinic receptors; 9 knockout mice

Indexed keywords

ALPHA CONOTOXIN RGIA; ALPHA CONOTOXIN VC1.1; ANALGESIC AGENT; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CALCIUM CHANNEL N TYPE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA9; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IC 50; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE CELL; SPINAL GANGLION; WESTERN BLOTTING;

GASTROPODA; MUS; RATTUS;

EID: 75749113276     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.4.1.11537     Document Type: Article

References (14)

1. Sandall DW, Satkunanathan N, Keays DA, Polidano MA, Liping X, Pham V, et al. A novel α-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. Biochemistry 2003; 42:6904-11.
2. Ellison M, Haberlandt C, Gomez-Casati ME, Watkins M, Elgoyhen AB, McIntosh JM, et al. α-RgIA: a novel conotoxin that specifically and potently blocks the α9α10 nAChR. Biochemistry 2006; 45:1511-7.
3. Satkunanathan N, Livett B, Gayler K, Sandall D, Down J, Khalil Z. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res 2005; 1059:149-58.
4. Vincler M, Wittenauer S, Parker R, Ellison M, Olivera BM, McIntosh JM. Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 2006; 103:17880-4.
5. Nevin ST, Clark RJ, Klimis H, Christie MJ, Craik DJ, Adams DJ. Are α9α10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Mol Pharmacol 2007; 72:1406-10.
6. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 1994; 79:705-15.
7. Sgard F, Charpantier E, Bertrand S, Walker N, Caput D, Graham D, et al. A novel human nicotinic receptor subunit, α10, that confers functionality to the α9-subunit. Mol Pharmacol 2002; 61:150-9.
8. B receptor activation. J Neurosci 2008; 28:10943-51.
9. Tedford HW, Zamponi GW. Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev 2006; 58:837-62.
10. Raingo J, Castiglioni AJ, Lipscombe D. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat Neurosci 2007; 10:285-92.
11. McIntosh JM, Absalom N, Chebib M, Elgoyhen AB, Vincler M. Alpha9 nicotinic acetylcholine receptors and the treatment of pain. Biochem Pharmacol 2009; 78:693-702.
12. Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J. α10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci USA 2001; 98:3501-6.
13. Tombler E, Cabanilla NJ, Carman P, Permaul N, Hall JJ, Richman RW, et al. G protein-induced trafficking of voltage-dependent calcium channels. J Biol Chem 2006; 281:1827-39.
14. Vetter DE, Liberman MC, Mann J, Barhanin J, Boulter J, Brown MC, et al. Role of α9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron 1999; 23:93-103.